137 related articles for article (PubMed ID: 19767091)
1. Progress in primary CNS lymphoma.
O'Brien PC; Seymour JF
Lancet; 2009 Oct; 374(9700):1477-8. PubMed ID: 19767091
[No Abstract] [Full Text] [Related]
2. Treatment approaches for primary CNS lymphomas.
Carrabba MG; Reni M; Foppoli M; Chiara A; Franzin A; Politi LS; Villa E; Ciceri F; Ferreri AJ
Expert Opin Pharmacother; 2010 Jun; 11(8):1263-76. PubMed ID: 20429667
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of central nervous system malignant lymphoma].
Nakamura O
No To Shinkei; 2005 Dec; 57(12):1043-9. PubMed ID: 16375189
[No Abstract] [Full Text] [Related]
4. Primary Oculocerebral Lymphoma: MTX Polychemotherapy Alone on Intraocular Disease Control.
Nguyen DT; Houillier C; Choquet S; Cassoux N; Soussain C; Le Cossec C; Legarf-Tavernier M; Costopoulos M; LeHoang P; Bodaghi B; Omuro A; Hoang-Xuan K; Touitou V
Ophthalmology; 2016 Sep; 123(9):2047-50. PubMed ID: 27137876
[No Abstract] [Full Text] [Related]
5. How important is whole brain radiotherapy for treatment of primary CNS lymphoma?
Cabanillas F
Lancet Oncol; 2010 Nov; 11(11):1011-2. PubMed ID: 20970379
[No Abstract] [Full Text] [Related]
6. [II. Primary treatment of CNS lymphoma with high-dose MTX].
Iwadate Y
Gan To Kagaku Ryoho; 2012 Jun; 39(6):892-7. PubMed ID: 22880222
[No Abstract] [Full Text] [Related]
7. High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial.
Thiel E; Korfel A; Martus P; Kanz L; Griesinger F; Rauch M; Röth A; Hertenstein B; von Toll T; Hundsberger T; Mergenthaler HG; Leithäuser M; Birnbaum T; Fischer L; Jahnke K; Herrlinger U; Plasswilm L; Nägele T; Pietsch T; Bamberg M; Weller M
Lancet Oncol; 2010 Nov; 11(11):1036-47. PubMed ID: 20970380
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate, cytarabine, thiotepa and rituximab (MATRix) chemoimmunotherapy for primary central nervous system lymphoma: a Toronto experience.
Suleman A; Liu J; Hicks LK; Drori AK; Crump M; Kridel R; Prica A; Berinstein N
Haematologica; 2023 Apr; 108(4):1186-1189. PubMed ID: 36453110
[No Abstract] [Full Text] [Related]
9. [Chemotherapy of primary cerebral lymphoma].
Delwail V; Bataille B
Neurochirurgie; 1997; 43(6):380-4. PubMed ID: 9706617
[TBL] [Abstract][Full Text] [Related]
10. Preliminary results of combined chemotherapy and radiotherapy for non-AIDS primary central nervous system lymphoma. Trans-Tasman Radiation Oncology Group (TROG).
O'Brien PC; Roos DE; Liew KH; Trotter GE; Barton MB; Walker QJ; Poulsen MG; Olver IN
Med J Aust; 1996 Oct; 165(8):424-7. PubMed ID: 8913243
[TBL] [Abstract][Full Text] [Related]
11. Primary CNS lymphoma: a clinician's guide.
Schäfer N; Glas M; Herrlinger U
Expert Rev Neurother; 2012 Oct; 12(10):1197-206. PubMed ID: 23082736
[TBL] [Abstract][Full Text] [Related]
12. Clinical utility and pharmacology of high-dose methotrexate in the treatment of primary CNS lymphoma.
Green MR; Chowdhary S; Lombardi KM; Chalmers LM; Chamberlain M
Expert Rev Neurother; 2006 May; 6(5):635-52. PubMed ID: 16734512
[TBL] [Abstract][Full Text] [Related]
13. High-dose methotrexate and temozolomide associated with intrathecal liposomal cytarabine for the treatment of primary or secondary central nervous system lymphoma: a preliminary experience.
Falchi L; Gunnellini M; Ferranti L; Liberati AM
Clin Neurol Neurosurg; 2012 Dec; 114(10):1376-8. PubMed ID: 22516417
[No Abstract] [Full Text] [Related]
14. Cognitive functions in primary central nervous system lymphoma patients treated with chemotherapy and stem cell transplantation: preliminary findings.
Correa D; Anderson ND; Glass A; Mason WP; DeAngelis LM; Abrey LE
Clin Adv Hematol Oncol; 2003 Aug; 1(8):490. PubMed ID: 16258439
[No Abstract] [Full Text] [Related]
15. Antimetabolites in combination with other drugs improve therapy of diffuse aggressive non-Hodgkin's lymphoma.
Odujinrin OO; Bertino JR
Cancer Invest; 1986; 4(2):139-48. PubMed ID: 3708418
[No Abstract] [Full Text] [Related]
16. MATILDE chemotherapy regimen for primary CNS lymphoma: results at a median follow-up of 12 years.
Ferreri AJ; Ciceri F; Brandes AA; Montanari M; Balzarotti M; Spina M; Ilariucci F; Zaja F; Stelitano C; Bobbio F; Corazzelli G; Baldini L; Reni M
Neurology; 2014 Apr; 82(15):1370-3. PubMed ID: 24634458
[TBL] [Abstract][Full Text] [Related]
17. Primary central nervous system lymphomas: salvage treatment after failure to high-dose methotrexate.
Reni M; Mazza E; Foppoli M; Ferreri AJ
Cancer Lett; 2007 Dec; 258(2):165-70. PubMed ID: 17993246
[TBL] [Abstract][Full Text] [Related]
18. High-dose chemotherapy with autologous stem-cell transplantation and hyperfractionated radiotherapy as first-line treatment of primary CNS lymphoma.
Illerhaus G; Marks R; Ihorst G; Guttenberger R; Ostertag C; Derigs G; Frickhofen N; Feuerhake F; Volk B; Finke J
J Clin Oncol; 2006 Aug; 24(24):3865-70. PubMed ID: 16864853
[TBL] [Abstract][Full Text] [Related]
19. Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemotherapy.
Dabaja BS; McLaughlin P; Ha CS; Pro B; Meyers CA; Seabrooke LF; Wilder RB; Kyritsis AP; Preti HA; Yung WK; Levin V; Cabanillas F; Cox JD
Cancer; 2003 Sep; 98(5):1021-8. PubMed ID: 12942571
[TBL] [Abstract][Full Text] [Related]
20. Successful salvage chemotherapy for isolated central nervous system (CNS) relapse in Burkitt lymphoma: monocentric experience of 3 pediatric patients.
Baleydier F; Pondarre C; Pages MP; Mialou V; Kebaili K; Pracros JP; Bertrand Y
J Pediatr Hematol Oncol; 2008 Dec; 30(12):972-5. PubMed ID: 19131795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
